Top Canopius leader and 40+ years Lloyd’s market vet appears at Aspen
Bermuda-based Aspen Insurance Holdings has appointed a 40-year London market veteran and Canopius’ most recent chief underwriting officer to its UK boards to support its growth trajectory and enhance value for all stakeholders.
Mike Duffy (pictured) is to join Aspen Managing Agency (AMAL) and Aspen Insurance UK (AIUK) boards as a non-executive director, effective February 1, 2023.
Duffy will join the AMAL and AIUK (together, Aspen UK) boards as senior independent non-executive director (SID), chair of the nominations committee, and chair of the governance committee, subject to regulatory approval.
Canopius revealed last May that Duffy is set to retire and leave the company in May 2023 after more than 16 years of service and more than 40-year insurance career. He has held numerous roles in the Lloyd’s and London market and abroad across underwriting and broking. He was most recently group chief underwriting officer for Canopius, where he held several Board roles across the Canopius corporate group of entities. In addition, he has held numerous leadership positions across a range of broking and insurance groups.
During his extensive career, Duffy gained significant risk, governance, transaction and regulatory experience across the UK, US, Bermuda and Singapore insurance and reinsurance markets.
Richard Milner, chief executive officer, Aspen UK, said: “I am delighted that Mike is joining the Aspen U.K. Boards. His extensive experience in the sector will add further depth and guidance. We look forward to welcoming his insights and expertise as we continue to deliver against our strategic vision for Aspen as a leading, global specialty insurer and reinsurer.”
Duffy commented: “I am excited to join the Aspen U.K. Boards at a time when the business is continuing to demonstrate its potential and deliver strong performance. I look forward to working with my fellow Board members, and the wider leadership team, to help Aspen continue its trajectory and deliver value for all its stakeholders.”
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze